100
Participants
Start Date
March 31, 2024
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Nebivolol
Nebivolol (Nebilet) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Valsartan and Sacubitril
Valsartan and Sacubitril (Entresto) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Carvedilol
Carvedilol (Dilatrend) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Bisoprolol
Bisoprolol (Concor) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Metoprolol
Metoprolol (Betaloc ZOK) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Spironolactone
Verospiron (Spironolactone) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
University Hospital Ostrava, Ostrava
University Hospital Ostrava
OTHER